Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05282186 · ClinicalTrials.gov registry record · NA
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT05282186 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 134 participants.
The verdict
NCT05282186, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
This project proposes to conduct the first study of the predictive utility of olfactory hedonic measurement for targeted psychosocial rehabilitation in schizophrenia. The information gathered from the project is of considerable public health relevance, in that, through simple, reliable olfactory assessment, it will provide knowledge about which individuals are most likely to benefit from these psychosocial interventions. Such information is crucial for tailoring existing interventions and developing new approaches to optimize outcomes in schizophrenia.
Interventions
- BEHAVIORAL Cognitive Enhancement Therapy
- BEHAVIORAL Social Skills Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2022-09-02 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05282186
The ClinicalTrials.gov registry entry for NCT05282186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Enhancement Therapy is the first listed.
NCT05282186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05282186 about?
NCT05282186 is a clinical study titled "What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia". This project proposes to conduct the first study of the predictive utility of olfactory hedonic measurement for targeted psychosocial rehabilitation in schizophrenia. The information gathered from the project is of considerable public health relevance, in that, through simple, reliable olfactory ass...
What is the current status of trial NCT05282186?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2022-09-02. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT05282186?
The interventions under investigation include: Cognitive Enhancement Therapy (BEHAVIORAL), Social Skills Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05282186?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.